GIM
TMO icon

Groesbeck Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Groesbeck Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803K Hold
1,602
– – 1.28% 19
2026
Q1 		$787K Hold
1,602
– – 1.53% 19
2025
Q4 		$928K Hold
1,602
– – 1.75% 17
2025
Q3 		$777K Sell
1,602
-1,140
-42% -$531K 1.52% 23
2025
Q2 		$1.11M Sell
2,742
-250
-8% -$105K 1.95% 17
2025
Q1 		$1.49M Hold
2,992
– – 2.08% 13
2024
Q4 		$1.56M Sell
2,992
-350
-10% -$192K 2.03% 13
2024
Q3 		$2.07M Sell
3,342
-160
-5% -$94.7K 3.04% 8
2024
Q2 		$1.94M Sell
3,502
-375
-10% -$215K 2.68% 9
2024
Q1 		$2.25M Buy
3,877
+100
+3% +$56.1K 2.4% 8
2023
Q4 		$2M Buy
3,777
+15
+0.4% +$7.26K 2.77% 8
2023
Q3 		$1.9M Buy
3,762
+100
+3% +$53.3K 2.88% 8
2023
Q2 		$1.91M Hold
3,662
– – 2.91% 7
2023
Q1 		$2.11M Hold
3,662
– – 3.16% 7
2022
Q4 		$2.02M Sell
3,662
-250
-6% -$132K 3.38% 5
2022
Q3 		$2.13M Hold
3,912
– – 3.5% 3
2022
Q2 		$2.13M Hold
3,912
– – 3.5% 3
2022
Q1 		$2.31M Hold
3,912
– – 2.59% 8
2021
Q4 		$2.61M Buy
3,912
+35
+0.9% +$21.9K 3.32% 5
2021
Q3 		$2.21M Sell
3,877
-15
-0.4% -$8.23K 2.56% 6
2021
Q2 		$1.96M Buy
3,892
+177
+5% +$83.5K 2.5% 8
2021
Q1 		$1.7M Buy
3,715
+175
+5% +$83.5K 2.44% 9
2020
Q4 		$1.65M Hold
3,540
– – 2.7% 8
2020
Q3 		$1.56M Sell
3,540
-50
-1% -$20.7K 2.93% 7
2020
Q2 		$1.3M Buy
3,590
+350
+11% +$117K 2.58% 9
2020
Q1 		$919K Buy
3,240
+400
+14% +$126K 2.47% 9
2019
Q4 		$923K Sell
2,840
-550
-16% -$167K 0.68% 47
2019
Q3 		$987K Buy
3,390
+115
+4% +$32.9K 0.74% 41
2019
Q2 		$962K Sell
3,275
-220
-6% -$60.6K 0.78% 38
2019
Q1 		$957K Sell
3,495
-200
-5% -$49.8K 0.73% 38
2018
Q4 		$827K Hold
3,695
– – 0.7% 40
2018
Q3 		$902K Buy
3,695
+20
+0.5% +$4.6K 0.61% 41
2018
Q2 		$761K Hold
3,675
– – 0.53% 48
2018
Q1 		$759K Hold
3,675
– – 0.55% 43
2017
Q4 		$698K Sell
3,675
-200
-5% -$38.3K 0.49% 48
2017
Q3 		$733K Hold
3,875
– – 0.53% 48
2017
Q2 		$676K Hold
3,875
– – 0.5% 47
2017
Q1 		$595K Buy
3,875
+100
+3% +$15.3K 0.44% 53
2016
Q4 		$533K Sell
3,775
-150
-4% -$22.1K 0.42% 59
2016
Q3 		$624K Sell
3,925
-350
-8% -$53.9K 0.46% 53
2016
Q2 		$632K Sell
4,275
-675
-14% -$99.6K 0.46% 54
2016
Q1 		$701K Sell
4,950
-600
-11% -$80.4K 0.5% 50
2015
Q4 		$787K Hold
5,550
– – 0.5% 53
2015
Q3 		$679K Hold
5,550
– – 0.43% 56
2015
Q2 		$720K Hold
5,550
– – 0.35% 62
2015
Q1 		$746K Sell
5,550
-550
-9% -$70.9K 0.36% 61
2014
Q4 		$764K Hold
6,100
– – 0.37% 61
2014
Q3 		$742K Hold
6,100
– – 0.35% 66
2014
Q2 		$720K Sell
6,100
-1,450
-19% -$171K 0.31% 67
2014
Q1 		$908K Sell
7,550
-1,225
-14% -$146K 0.41% 56
2013
Q4 		$977K Sell
8,775
-4,525
-34% -$450K 0.41% 54
2013
Q3 		$1.23M Sell
13,300
-300
-2% -$27.1K 0.53% 49
2013
Q2 		$1.15M Buy
+13,600
New +$1.13M 0.49% 49

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Groesbeck Investment Management's TMO Position: Q2 2026 in Review

Groesbeck Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,602 shares worth $803K. The position accounts for 1.28% of the portfolio, ranked #19.

Groesbeck Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.61M in Q4 2021. 817 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Groesbeck Investment Management held 1,602 shares of Thermo Fisher Scientific worth $803K as of Q2 2026.
  • Groesbeck Investment Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 1.28% of Groesbeck Investment Management's portfolio in Q2 2026, its #19 holding.
  • Groesbeck Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Groesbeck Investment Management's Thermo Fisher Scientific position peaked at $2.61M in Q4 2021.
  • 817 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.